Power Grid Corporation of India will hold a meeting of the Board of Directors of the Company on 17 March 2022
Wockhardt announced that National Institute of Allergy and Infectious Diseases NIAID part of the National Institutes of Health NIH United States of America USA is supporting a Phase 1 clinical trial of Wockhardts novel once-a-day multidrug-resistant MDR Gram-negative targeted antibiotic WCK 6777 The trial will be conducted at NIAIDs Phase I clinical trial units in the USA NIAID will sponsor the investigational new drug IND […]
Bharat Petroleum Corporation announced that an Extra Ordinary General Meeting EGM of the Company will be held on 21 April 2022
Sky Industries has approved the allotment of 61096 Equity Shares of face value of Rs 10 each of the Company to Options Grantee upon Exercise of Options vested under ESOP 2018
Ushanti Colour Chem will hold a meeting of the Board of Directors of the Company on 16 March 2022
Shree Cement has commenced trial run of its new Clinkerisation Unit Kiln -3 at Baloda Bazar near Raipur in Chhattisgarh This clinkerisation unit shall augment Companys clinker supply to its various grinding units in Eastern region The Company has also set up Waste Heat Recovery Power unit alongside the kiln which will produce green power and help meet Companys power requirement This brownfield investment in […]
The equity shares of Eureka Forbes Scrip Code 543482 are listed effective 16 March 2022 and admitted to dealings on the Exchange in the list of T Group Securities
Unichem Laboratories has received ANDA approval for its Nebivolol Tablets 25 mg 5 mg 10 mg and 20 mg from the United States Food and Drug Administration USFDA to market a generic version of Bystolic nebivolol Tablets 25 mg 5 mg 10 mg and 20 mg of Allergan Sales LLC Nebivolol Tablets are indicated for the treatment of hypertension The product will be commercialized from […]
Brand Concepts will hold a meeting of the Board of Directors of the Company on 23 March 2022
The Board of D B Realty at its meeting held on 16 March 2022 has allotted 127000000 warrants convertible into equal number of equity shares of Rs 10 each of the company at an issue price of Rs 7725 per warrant including premium of Rs 6725 per warrant on preferential basis
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
